API Gallery

The Octenidine Dihydrochloride market is projected to grow steadily between 2025 and 2035, registering a CAGR of 6.2% during the forecast period. This growth is primarily driven by the increasing demand for effective antiseptics in healthcare settings, heightened awareness of hygiene, and the rising prevalence of healthcare-associated infections.
The Octenidine Hydrochloride market is projected to grow steadily between 2025 and 2035, registering a CAGR of 6.2% during the forecast period. This growth is primarily driven by the increasing demand for effective antiseptics in healthcare settings, heightened awareness of hygiene, and the rising prevalence of healthcare-associated infections.
The Polyethylene Glycol (PEG) market is expected to grow at a CAGR of 5.6% from 2025 to 2035, driven by its broad utility as a solubilizer, plasticizer, lubricant, and base for a variety of pharmaceutical formulations.
The Polymyxin B Sulfate market is expected to grow at a CAGR of 5.7% from 2025 to 2035. Polymyxin B Sulfate is a critical antibiotic used for treating multidrug-resistant Gram-negative infections, especially in serious conditions such as sepsis and meningitis.
The Polysorbate market is projected to expand at a CAGR of 5.1% from 2025 to 2035, driven by its broad applications across pharmaceuticals, food, and cosmetic industries. Polysorbates are nonionic surfactants widely used for their emulsifying, stabilizing, and solubilizing properties.
The Pomalidomide market is projected to grow at a CAGR of 5.8% from 2025 to 2035, driven by rising cases of multiple myeloma and a growing emphasis on targeted cancer therapies.
The Odevixibat market is projected to grow steadily between 2025 and 2035, registering a CAGR of 6.2% during the forecast period. This growth is primarily driven by the increasing prevalence of rare pediatric cholestatic liver diseases, such as Progressive Familial Intrahepatic Cholestasis (PFIC) and Alagille Syndrome (ALGS), along with the rising demand for effective treatments like Odevixibat.
The Ofloxacin API market is projected to grow steadily between 2025 and 2035, registering a CAGR of 4.8% during the forecast period. This growth is primarily driven by the increasing prevalence of bacterial infections, rising demand for affordable generic antibiotics, and advancements in pharmaceutical manufacturing technologies.
The Ponesimod market is projected to grow at a CAGR of 7.4% from 2025 to 2035, primarily driven by increasing diagnoses of multiple sclerosis (MS) and the rising demand for oral disease-modifying therapies (DMTs).
The Posaconazole market is projected to grow at a CAGR of 6.8% from 2025 to 2035, primarily driven by the rising incidence of fungal infections, particularly among immunocompromised populations.

Search from 10,000 + API reports

How can we help you?

Reach out to discuss how our team can help your business achieve real results.